BeOne Medicines AG
ONC
$315.07
$4.321.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 230.75% | 144.50% | 108.28% | 64.95% | 48.88% |
| Total Depreciation and Amortization | -20.11% | -21.16% | -27.54% | 98.99% | 97.16% |
| Total Amortization of Deferred Charges | 124.05% | 111.55% | 32.35% | 108.89% | 14.80% |
| Total Other Non-Cash Items | 7.34% | 3.78% | 7.08% | 1,288.91% | 1,970.50% |
| Change in Net Operating Assets | 199.93% | 221.46% | 101.67% | 112.66% | 65.20% |
| Cash from Operations | 505.99% | 901.80% | 228.44% | 183.80% | 124.10% |
| Capital Expenditure | 56.63% | 62.28% | 54.16% | 42.78% | 32.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.59% | -62.19% | 66.13% | -797.01% | -137.69% |
| Cash from Investing | 56.63% | 49.64% | 58.20% | 28.32% | -14.67% |
| Total Debt Issued | 31.78% | 23.59% | -8.21% | -8.87% | -3.46% |
| Total Debt Repaid | -0.57% | -47.55% | -159.01% | 17.63% | -2.56% |
| Issuance of Common Stock | 66.91% | 332.59% | 392.57% | -19.94% | -37.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 6.81% | 6.81% |
| Other Financing Activities | 29,158.60% | 29,352.13% | 4,045.55% | 100.00% | 102.68% |
| Cash from Financing | 44,428.88% | 447.66% | 65.43% | -97.93% | -100.44% |
| Foreign Exchange rate Adjustments | 394.19% | 216.09% | -4.08% | -75.56% | 37.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 939.04% | 460.15% | 266.42% | 121.19% | 61.88% |